Abstract
This editorial refers to ‘Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data’, by M. Krogager et al . doi:10.1093/eurheartj/ehw129 There has been considerable focus on the risks of hyperkalaemia, especially in patients with chronic kidney disease (CKD), diabetes mellitus, and/or heart failure.1–3 Although the exact level of serum potassium (K+) that is associated with an increase in mortality remains controversial, increasing evidence suggests that in patients with CKD, diabetes mellitus, and/or heart failure, especially the elderly, a K+ >5.0 mmol/L is associated with an increased risk of death.4 Conversely, while a K+ 40 000 patients with hypertension taking a dual single antihypertensive drug. Patients with renal insufficiency, those with missing …

This publication has 14 references indexed in Scilit: